What is the market capitalization of CalciMedica, Inc.?

CalciMedica, Inc. (CALC) has a market capitalization of approximately 13,431,486 USD.

Where can I buy CALC in Canada?

CALC can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

CALC

CalciMedica, Inc.

CalciMedica, Inc. (CALC) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 13 million USD (micro-cap).

Details

Price0.85 USD

Market cap13.43 M USD

Payout ratio0.00%

ROE-399.51%

SectorHealthcare

Websitecalcimedica.com

Updated 2h ago

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.